Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT01791751
• Date of registration: 12/11/2012
• Prospective Registration: No
• Primary sponsor: Fundació Privada Eugin
• Public title: Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles CLOFA
• Scientific title: Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in Agonist Triggered GnRH Antagonist in Vitro Fertilization Cycles. Phase IV, Single-centre, Open-label, Controlled Clinical Trial.
• Date of first enrolment: June 2012
• Target sample size: 10
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT01791751
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label
• Phase: Phase 4

Countries of recruitment

Spain

Contacts

• Name: Marta Colodron, MD
• Affiliation: Clinica EUGIN

Key inclusion & exclusion criteria

Inclusion Criteria:

- Oocyte donors

- 18-35 years old

- BMI 18-29 Kg/m2

- Normal basal hormonal levels

- No contraceptive pill

Exclusion Criteria:

- Polycystic ovarian syndrome (PCOS)

- Previous participation in the study



Age minimum: 18 Years
Age maximum: 35 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Female Infertility

Intervention(s)

Drug: Clomifene Citrate

Primary Outcome(s)

LH Levels (IU) [Time Frame: Luteal phase (up to 2 weeks)]

Secondary Outcome(s)

Endometrial development (Noyes criteria) [Time Frame: Luteal phase (1 day)]

Secondary ID(s)

CLOFA

2011-002173-33

Source(s) of Monetary Support

Please refer to primary and secondary sponsors